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BACKGROUND: Physicians rely upon chest pain history to make management decisions in patients with
suspected acute coronary syndromes, particularly where the diagnosis is not immediately apparent through
electrocardiography and troponin testing. The objective of this study was to establish the discriminatory
value of “typicality of chest pain” and the effect of clinician experience, for the prediction of acute
myocardial infarction and presence of signiﬁcant coronary artery disease.
METHODS: This prospective single-center observational study was undertaken in a UK General Hospital
emergency department. We recruited consecutive adults with chest pain and a nondiagnostic electrocar-
diogram, for whom the treating physician determined that delayed troponin testing was necessary. Using
their own clinical judgment, physicians recorded whether the chest pain described was typical or atypical
for acute coronary syndrome. Physicians were deﬁned as “experienced” or “novice” according to post-
graduate experience. Acute myocardial infarction was adjudicated using a high-sensitivity troponin
(hs-cTn) assay, whereas coronary artery disease was adjudicated angiographically.
RESULTS: Overall, 912 patients had typicality of chest pain assessed, of whom 114/912 (12.5%) had an
acute myocardial infarction and 157/912 (17.2%) underwent angiography. In patients undergoing angi-
ography, 90/157 (57.3%) had hs-cTn elevation, of whom 60 (66.7%) had signiﬁcant coronary artery dis-
ease. Sixty-seven of 157 (42.7%) patients had angiography without hs-cTn elevation; of these, 31 (46.2%)
had signiﬁcant coronary artery disease. For the diagnosis of acute myocardial infarction, chest pain typi-
cality had an area under the curve (AUC) of 0.54 (95% conﬁdence interval [CI], 0.49-0.60). For the
prediction of signiﬁcant coronary artery disease with hs-cTn elevation AUC: 0.54 (95% CI, 0.40-0.67), and
without hs-cTn elevation AUC: 0.45 (95% CI, 0.31-0.59). When assessed by experienced physicians,
speciﬁcity for the diagnosis of acute myocardial infarction was higher at 65.8% (95% CI, 63.1%-68.7%) vs
55.4% (95% CI, 53.9%e56.8%) for novices.
CONCLUSIONS: Subjective interpretation of “typicality of chest pain” is of limited discriminatory value in the
assessment of suspected acute coronary syndromes, in the context of a nondiagnostic electrocardiogram.Greater
clinical experience improves accuracy as a rule-in tool but does not improve overall discriminatory ability.
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1110 The American Journal of Medicine, Vol 128, No 10, October 2015Patients with chest pain symptoms suggestive of acute
coronary syndromes account for 10% of all emergency
department attendances.1 Yet, only 15%-20% have a ﬁnal
diagnosis of acute coronary syndrome.2 In the remainder,
distinguishing whether a patient presenting with chest
pain has an acute coronary syndrome or a non cardiacCLINICAL SIGNIFICANCE
 In emergency patients being assessed
for potential acute coronary syndromes
with a nondiagnostic electrocardiogram,
where troponin results are not yet
available, typicality of chest pain is of
limited discriminatory value in the pre-
diction of acute myocardial infarction or
the presence of signiﬁcant coronary ar-
tery disease.
 The diagnostic accuracy of chest pain
typicality for the rule-in of acute
myocardial infarction appears to be
greater with a higher level of clinical
experience, but this effect is small.problem is difﬁcult.3 While some
alternative diagnoses become
apparent using history alone, the
ongoing diagnostic uncertainty in
the remainder of patients has
been shown to lead to emergency
department overcrowding, higher
levels of resource use, and
increased health care costs.4-6
In patients with chest pain and
potential acute coronary syn-
drome, clinical assessment in-
cludes electrocardiography and the
results of cardiac troponin
testing.7 However, over half of
patients will have a nondiagnostic
electrocardiogram (ECG),2 and at
least 10% with unstable angina
will not have troponin elevations,
even in the era of high-sensitivity
assays.8 This sizeable group of
patients represents a signiﬁcant diagnostic and resource
challenge. In these situations, physicians often use the
perceived discriminatory value of the chest pain history.
This will assist in deciding whether a patient is more or less
likely to have cardiac chest pain, and the subsequent need
for further observation and investigation.9
Published data demonstrate that typical symptoms
provide useful diagnostic information in patients with
stable coronary artery disease.10-12 In contrast, evidence
examining the value of typical symptoms in patients
presenting with chest pain in the acute setting have
demonstrated a poor correlation with the ﬁnal diagnosis
of acute coronary syndrome.3,13-19 However, these studies
have tended to either include patients with diagnostic
ECG changes, focus on speciﬁc chest pain characteristics
rather than overall typicality, or use research nurses to
extract this information. Although it is evident that un-
structured clinical judgment, or gestalt, has an important
role to play in the overall risk assessment of acute chest
pain patients,20 the subjective interpretation of typicality
of chest pain and the impact that clinical experience
may have upon its diagnostic accuracy remain poorly
understood.
This study therefore aimed to establish, in patients
presenting with chest pain and potential acute coronary
syndrome with a nondiagnostic ECG, the discriminatory
value of “typicality of chest pain” and the effect
of clinical experience, for the prediction of acute
myocardial infarction and presence of signiﬁcant coro-
nary artery disease.METHODS
Study Design and Setting
This was a planned substudy of a single-center prospective
diagnostic cohort study undertaken from July 2012 to
August 2013. This study was designed to assess physicianrisk assessment of emergency
department patients with chest
pain using an accelerated diag-
nostic pathway, the results of
which have been published previ-
ously.21 It was approved by the
UK National Research Ethics
Service, registered with the
Controlled Trials Database
(ISRCTN No. 21109279), and
designed using the Standards for
Reporting Diagnostic Accuracy.22
All patient participants provided
written informed consent. The
study institution’s Emergency
Department was situated within a
UK District General Hospital and
has approximately 62,000 new
patient attendances per year.Selection of Participants
We recruited consecutive adults of at least 18 years of age,
who had a primary complaint of chest pain, and for whom
the treating physician in the Emergency Department deter-
mined that delayed (6 hours post attendance) troponin
testing was required for the assessment of an acute coronary
syndrome. Clinical protocols at the time of the study did not
include troponin testing at presentation, unless >12 hours
had elapsed since peak symptoms, therefore, assessing
physicians were blinded to initial troponin results. In order
to focus upon the patient group that provides the greatest
diagnostic challenge to physicians, patients were recruited
only if they had a nondiagnostic ECG. Patients who were
discharged directly from the emergency department at the
discretion of the treating physician without delayed troponin
testing were not recruited. All patients who required 6-hour
troponin testing were admitted to an inpatient assessment
unit under the care of an acute general internist; the decision
to admit was at the discretion of the assessing physician in
the emergency department. Onward cardiology consultation,
stress testing, or discharge for outpatient follow-up was at
the discretion of the acute internist. Referral for invasive
angiography was at the discretion of cardiologists.
Recruitment was undertaken 24 hours a day, 7 days a week.
Patients were screened by a dedicated researcher and
assessed for eligibility and consented in collaboration with
the treating physician. Patients were excluded if any of
the following were present: ST-segment elevation myocar-
dial infarction or left bundle branch block not known to
be old, ECG changes diagnostic of ischemia (ST-segment
Carlton et al Chest Pain Typicality 1111depression 1 mm or T-wave inversion consistent with the
presence of ischemia), arrhythmias (new-onset atrial ﬁbril-
lation, atrial ﬂutter, sustained supraventricular tachycardia,
second-degree or complete heart block, or sustained or
recurrent ventricular arrhythmias), troponin not suitable for
analysis (eg, hemolysis), age 80 years, a clear nonacute
coronary syndrome cause for chest pain was found at pre-
sentation (eg, pulmonary embolism, pneumonia, aortic
dissection), another medical condition requiring hospital
admission, refusal or inability to give informed consent,
non-English-speaking, pregnancy, renal failure requiring
dialysis, or inability to be contacted after discharge.Methods and Measurements
On-duty Board Certiﬁed Attendings, Senior Emergency
Medicine Residents, and Junior Residents all undertook
assessments of pain typicality during the study period and
completed standardized data collection forms after genuine
clinical consultations and before obtaining results of diag-
nostic tests (other than the initial ECG). To standardize
recruitment, ECG evaluation was undertaken by members of
the research team. A trained researcher reviewed the hos-
pital record to collect data on the level of clinical experience
of the assessing physician, cardiovascular history, cardiac
risk factors, and all investigations related to the visit
according to standardized data deﬁnitions.23
We instructed clinicians to record whether they thought
the chest pain described was typical cardiac chest pain in a
“yes” or “no” tick box, using their own clinical judgment
and taking into account all factors from history and exam-
ination. The level of experience for assessing physicians
was recorded. Clinical experience was deﬁned a priori as
either “experienced” or “novice.” Experienced physicians
were either Board Certiﬁed Attendings (Fellows of the UK
College of Emergency Medicine) or Senior Residents with
at least 2 years of emergency department experience. Novice
physicians were Junior Residents with <1 years’ emergency
department experience. During the study period there were
12 experienced physicians and 32 novice physicians un-
dertaking clinical assessments.
Each participating patient had pain typicality assessed by
only one treating physician. As such, if a patient had a
primary consultation with a novice physician, followed by a
review by an experienced physician, only the interpretation
of the primary assessing physician was recorded.
The ﬁfth-generation Roche ELECSYS high-sensitivity
troponin-T assay (Roche, Basel, Switzerland), which has a
99th percentile reference limit of 14 ng/L and 10% coefﬁ-
cient of variation of <10% at 9 ng/L, was used for both
presentation and 6-hour samples. All serum samples were
tested in real time.
In order to provide a quantitative measure of pretest
probability and ensure provider groups were similar in this
regard, researchers calculated the Thrombolysis in
Myocardial Infarction (TIMI) Score24 for each patient. This
was assessed from data available at presentation and withoutknowledge of either the treating physicians’ interpretation of
chest pain typicality or troponin results.Outcomes
The primary endpoint was the diagnosis of fatal or nonfatal
acute myocardial infarction occurring during the index visit.
The presence of acute myocardial infarction was deﬁned
according to the Third Universal Deﬁnition, which states
that an increase or decrease in troponin with at least one
value above the 99th centile value in the context of a patient
with ischemic symptoms or signs (ECG changes or imaging
evidence) would satisfy the diagnosis.25 Based on current
consensus guidance for high-sensitivity troponin assays, an
increase or decrease of 20% (delta) was considered statis-
tically signiﬁcant and consistent with a diagnosis of acute
myocardial infarction.26 Adjudication of this endpoint was
carried out by 2 local cardiologists blinded to the physician
interpretation of typical pain, but whom had access to the in-
hospital clinical record, General Practitioner records, ECG,
troponin, and angiography results.
In order to overcome the diagnostic adjudication chal-
lenges associated with high-sensitivity troponin assays, such
as small elevations in troponin,27 and evaluate those patients
without troponin elevation that have clinically relevant
coronary artery disease, we also included a secondary
diagnostic outcome measure for those patients assessed
angiographically. This was categorized into the presence of
signiﬁcant coronary artery disease with or without high-
sensitivity troponin-T elevation (hs-cTnT 14 ng/L at
either presentation or 6 hours later vs hs-cTnT <14 ng/L at
presentation and 6 hours later). Signiﬁcant coronary artery
disease was deﬁned as 70% luminal diameter narrowing of
at least one major coronary artery as reported on visual
assessment by the operator.Analysis
As this was a planned substudy, no formal power calculation
was undertaken, however, previous observational studies
reporting the diagnostic utility of chest pain characteristics
have typically recruited upwards of 400 participants.13,14,16-19
Chi-squared analyses were used to generate 2  2 tables
for the calculation of sensitivity and speciﬁcity; 95% con-
ﬁdence intervals (CI) are reported. Receiver-operating
characteristic curves were obtained by plotting sensitivity
against 1-speciﬁcity. The area under the receiver-operating
characteristic curve (AUC) was chosen as the primary
measure of discriminatory value, as it gives a global mea-
sure of diagnostic test performance. The AUC was tested
against the null hypothesis that typicality of chest pain has
no discriminatory ability in determining the presence or
absence of acute myocardial infarction or signiﬁcant coro-
nary artery disease, and therefore the true AUC was 0.50,
with a signiﬁcance of <.05. AUC equals 0.5 when the
diagnostic test corresponds to random chance (null hy-
pothesis) and 1.0 indicates perfect diagnostic accuracy. For
1112 The American Journal of Medicine, Vol 128, No 10, October 2015analysis of the effect of clinical experience, sensitivity
(ability of the test to rule out a condition) and speciﬁcity
(ability of the test to rule in) were compared. All reported P-
values are 2-tailed. Statistical analysis was carried out using
SPSS version 20 (IBM, Armonk, NY).RESULTS
Characteristics of Study Subjects
Overall, 912 patients had typicality of chest pain assessed, of
whom 394 (43%) were recorded as having had typical chest
pain (Figure 1). Acute myocardial infarction occurred in
114/912 (12.5%), and 157/912 (17.2%) underwent
angiographic assessment. In those undergoing angiography,
90 (57.3%) had hs-cTnT elevation, of whom 64 (71.1%) had
signiﬁcant coronary artery disease. In the 67 (42%) patients
who had angiography without hs-cTnT elevation, 28 (41.7%)
had signiﬁcant coronary artery disease, of whom 21 (67.7%)
required percutaneous coronary intervention.
Of the assessments for typicality of chest pain, 227 (24.9%)
were made by experienced emergency department physicians
and 685 (75.1%) were made by novices. Table 1 summarizes
recruited patient demographics according to physician
experience; there were no signiﬁcant differences in clinical
characteristics or outcomes (P > .05 for all). When assessed
by experienced physicians, a lower proportion of patients
were identiﬁed as having typical chest pain when compared
with novices (35.2% vs 45.8%, P ¼ .005).
Table 2 demonstrates that there was no signiﬁcant
difference in quantitative pretest probability betweenFigure 1 Participant recruitment ﬂow chart. AMI ¼ acute myo
electrocardiogram.provider groups when assessed using the TIMI score (in
the absence of troponin results).
Contingency tables showing the occurrence of acute
myocardial infarction and signiﬁcant coronary artery dis-
ease, with and without hs-cTn elevation according to the
presence or absence of typical chest pain, are shown in the
Appendix (available online).
Discriminatory Value of Typicality of Chest Pain
The receiver-operating characteristic curves demonstrating the
discriminatory ability of typicality of chest pain as assessed by
all physicians in the emergency department, either as a diag-
nostic tool for acute myocardial infarction, or signiﬁcant cor-
onary artery disease both with and without hs-cTn elevation,
are presented in Figure 2. Below this are also listed the values
for AUCs according to speciﬁc provider groups. When tested
against the null hypothesis that the true AUC is 0.50, the P-
value for all providers is >.05, suggesting that typicality of
chest pain has limited discriminatory ability in the diagnosis
or exclusion of acute myocardial infarction and signiﬁcant
coronary artery disease with or without hs-cTn elevation in
this cohort across all providers.
Diagnostic Accuracy and Impact of Clinical
Experience
Figure 3 presents the sensitivity and speciﬁcity of typicality of
chest pain for the diagnosis of acute myocardial infarction and
signiﬁcant coronary artery disease both with and without hs-
cTn elevation, according to provider groups. As a rule-in tool,cardial infarction; CAD ¼ coronary artery disease; ECG ¼
Table 1 Patient Characteristics According to Provider Groups
Total
(N ¼ 912)
Experienced Physicians
(n ¼ 227)
Novice Physicians
(n ¼ 685)
Age, y (Mean/SD) 58.0/13.3 58.5/12.8 57.8/13.4
Male sex (%) 546 (59.9) 137 (60.4) 409 (59.7)
Ethnicity (% White British) 869 (95.3) 219 (96.5) 650 (94.9)
Risk factors, n (%)
Hypertension 505 (55.4) 126 (55.4) 379 (55.3)
Hyperlipidemia 601 (65.9) 154 (67.8) 447 (65.3)
Smoking Current 219 (24.0) 61 (26.9) 158 (23.1)
Diabetes 152 (16.7) 31 (13.7) 121 (17.7)
Family History of CAD 340 (37.3) 78 (34.4) 262 (38.2)
Medical history
Angina 238 (26.1) 51 (22.5) 187 (27.3)
Myocardial infarction 194 (21.3) 42 (18.5) 152 (22.2)
Percutaneous coronary intervention 173 (19.0) 40 (17.6) 133 (19.4)
Atrial arrhythmia 115 (12.6) 26 (11.5) 89 (13.0)
Stroke/TIA 62 (6.8) 14 (6.2) 48 (7.0)
Coronary artery bypass graft 47 (5.2) 11 (4.8) 36 (5.3)
Typical chest pain present 394 (43.2) 80 (35.2) 314 (45.8)
Outcomes
Fatal/nonfatal AMI 114 (12.5) 34 (14.9) 80 (11.6)
Signiﬁcant CAD with troponin elevation 64 (7.0) 19 (8.3) 45 (6.5)
Signiﬁcant CAD without troponin elevation 28 (3.1) 10 (4.4) 18 (2.6)
No signiﬁcant difference seen between physician groups; P > .05 for all variables.
AMI ¼ acute myocardial infarction; CAD ¼ coronary artery disease; TIA ¼ transient ischemic attack.
Carlton et al Chest Pain Typicality 1113speciﬁcity of typical chest pain for all outcomes, when adjudi-
cated by physicians as awhole, ranged from51.3%-57.9% (95%
CI, 40.8%-70.8%). However, when assessing the ability of
typicality of chest pain as a rule-in tool according to physician
experience, the speciﬁcity for the diagnosis of acute myocardial
infarctionwas higher for experienced physicians, at 65.8% (95%
CI, 63.1%-68.7%), compared with novices at 55.4% (95% CI,
53.9%-56.8%). Similarly, in patients with signiﬁcant coronary
artery disease without hs-cTnT elevation, there was a trend to-
ward higher speciﬁcity when assessed by experienced physi-
cians: 66.7% (95% CI, 48.8%-89.5%) vs 46.7% (95% CI,
34.8%-58.6%). It is important here to note that this ﬁnding was
not statistically signiﬁcant due to wide and overlapping 95%
conﬁdence intervals. In patients with signiﬁcant coronary arteryTable 2 Quantitative Estimates of Pretest Probability Using the TIMI
According to Provider Groups
TIMI Score*
Total N (%)
Total
(n ¼ 912)
Experienced Physicians
(n ¼ 227)
Novice
(n ¼ 6
0 210 (23) 50 (22) 160 (23
1 285 (31.3) 80 (35.2) 205 (29
2 157 (17.2) 33 (14.5) 124 (18
3 175 (19.2) 42 (18.5) 133 (19
4 77 (8.4) 20 (8.8) 57 (8.
5 8 (0.9) 2 (0.9) 6 (0.
*The Thrombolysis in Myocardial Infarction (TIMI) Score24 was calculated f
without the knowledge of troponin results: 1) Age 65 years or older; 2) Three or
hyperlipidemia, diabetes or being a current smoker); 3) Use of aspirin in the past
angina events in the past 24 hours). One point was assigned for each variabledisease and hs-cTnT elevation, there was no difference in test
speciﬁcity between physician groups: 54.5% (95% CI,
28.8-79.4) vs 53.3% (95% CI, 29.6-75.9).
As a rule-out tool for all outcomes, sensitivity of typicality
of chest pain ranged from 39.3%-53.1% (95% CI,
24.7%-60.6%). There was no signiﬁcant difference in the
ability of typicality of chest pain to act as a rule-out tool for
any outcome measure when comparing experienced and
novice physicians.DISCUSSION
Physicians rely upon chest pain history to make management
decisions in patients with suspected acute coronary syndromes,Risk Score,24 in the Absence of High-sensitivity Troponin Results,
Physicians
85)
Signiﬁcance of Difference Between Experienced
and Novice Physicians (P-value)
.4) .680
.9) .134
.1) .218
.4) .762
3) .818
9) .990
rom the following 5 parameters from data available at presentation and
more risk factors for coronary artery disease (family history, hypertension,
7 days; 4) Signiﬁcant coronary artery stenosis; 5) Severe angina (2 or more
present.
Figure 2 Discriminatory ability of the typicality of chest pain for either acute myocardial infarction, or signiﬁcant coronary artery
disease with and without high-sensitivity troponin-T elevation.
1114 The American Journal of Medicine, Vol 128, No 10, October 2015where the diagnosis is not immediately apparent through ECG
and troponin testing.Our results show that in emergency patients
being assessed for a potential acute coronary syndrome with a
nondiagnostic ECG,where troponin results are not yet available,
typicality of chest pain is of limited discriminatory value in the
prediction of acute myocardial infarction or the presence of
signiﬁcant coronary artery disease. With regard to clinician
experience, the diagnostic accuracy for the rule-in of acute
myocardial infarction appears to be greater with more experi-
ence, but this difference is small and therefore likely to have
limited clinical applicability.
Our report has several important implications. Physicians
intuitively adopt a Bayesian approach to diagnosis, making
an initial diagnosis based on probabilities, then adjusting
these probabilities as more information becomes available.28
This diagnostic approach is applied readily in the risk
assessment of patients with acute chest pain. In the absence
of diagnostic ECG changes, physicians weigh up all the
information gathered from the history and physical assess-
ment to establish pretest probability before the results of
troponin testing. Chest pain typicality has been traditionallycentral to this assessment, yet our results bring its value into
question.
Until recently, contemporary cardiac troponin assays
could be used reliably to identify those patients with a non-
ischemic ECG who were at high risk for acute myocardial
infarction and adverse events with low false-positive rates.7
However, the development of high-sensitivity cardiac
troponin assays, which can detect troponin in over 50% of
apparently illness-free individuals,26 has raised concerns
around binary positive and negative interpretation of results.
The potential for multiple acute conditions to cause elevations
in hs-cTn29 has necessitated better estimates of pretest
probability to allow improved management decisions based
on elevated hs-cTn results. Our results suggest that chest pain
typicality may also be of limited use in this regard.
With the advent of high-sensitivity assays, there was the
potential that in clinical practice, their use may make the diag-
nosis of unstable angina obsolete.30 By using hs-cTn to adjudi-
cate our primary endpoint and conﬁrm the ﬁndings in a subset of
patients who have undergone angiographic assessment, we have
demonstrated an important ﬁnding. In our cohort, over 40% of
Figure 3 Sensitivities and speciﬁcities of typicality of chest pain for the diagnosis of acute myocardial infarction and signiﬁcant
coronary artery disease with and without high-sensitivity troponin elevation.
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tery disease, in the absence of high-sensitivity troponin eleva-
tions, and two-thirds of these required intervention. It is these
patients in whom treating physicians most rely on the discrimi-
natory value of the chest pain history, yet we demonstrate that
typicality may again be of limited use.
We therefore suggest that there should be a focus on the
clinical application of accelerated diagnostic protocols,
which combine risk scores with high-sensitivity troponin
testing21,31-34 rather than unstructured subjective clinical
assessment or gestalt.20
Importantly, this study included only patients with chest
pain and a potential acute coronary syndrome with a non-
diagnostic ECG who were admitted to a ward for delayed
biomarker testing. As a result, the treating clinician had already
used clinical judgment to identify patients with chest pain in
whom there was a high level of suspicion for acute coronary
syndrome and therefore required further inpatient evaluation.
Those patients with diagnostic ECGs and those discharged
directly from the emergency department with “non-concern-
ing” histories were, as a result, intentionally excluded from
analysis. Although our population therefore may be subject to
signiﬁcant selection bias, we have focused intentionally on a
cohort of patients that provide the greatest diagnostic challenge
for acute physicians on a day-to-day basis. It is possible that
the discriminatory value of typicality of chest pain would have
improved if patients with clinically evident acute coronary
syndromes also had been recruited for analysis. However, the
exclusion of those patients in whom there was no diagnostic
uncertainty has allowed us to provide novel insight into an
everyday and highly relevant clinical problem.
There are some limitations to this study. The applicability of
the results may be limited by the characteristics of the popu-
lation selected. The inclusion of predominantly white patients
may limit the applicability to international settings, especially
as cross-cultural differences in symptom reporting exist.18 The
upper age cut-off of 80 years was chosen for pragmatic
institutional reasons, as patients were cared for by different
inpatient teams. Thismay limit further the general applicability
of the ﬁndings, as ﬁrstly, older individuals are more likely to
report atypical symptoms35 and secondly, older cohorts areknown to have high proportions of patients with elevated hs-
cTn assay results, often due to subclinical disease.36CONCLUSION
Physician interpretation of “typicality of chest pain” is of
limited discriminatory value in patients being assessed for
potential acute coronary syndromes, in the context of a
nondiagnostic ECG. Greater clinical experience improves
accuracy as a rule-in tool for acute myocardial infarction,
but this does not improve overall discriminatory ability.
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Contingency tables showing the occurrence of acute myocar-
dial infarction (Supplementary Table 1) and signiﬁcant
coronary artery disease with and without troponin elevation
(Supplementary Table 2) according to the presence or
absence of typical chest pain.Supplementary Table 1 The occurrence of acute myocardial
infarction according to the presence or absence of typical chest
pain
Acute
Myocardial
Infarction
No Acute
Myocardial
Infarction Total
All physicians
Typical chest
pain present
58 336 394
Typical chest
pain absent
56 462 518
Total 114 798 912
Experienced physicians
Typical chest
pain present
14 66 80
Typical chest
pain absent
20 127 147
Total 34 193 227
Novice physicians
Typical chest
pain present
44 270 314
Typical chest
pain absent
36 335 371
Total 80 605 685
Supplementary Table 2 The occurrence of signiﬁcant coronary artery disease with and without troponin elevation according to the
presence or absence of typical chest pain
Signiﬁcant Coronary Artery
Disease and hs-cTnT 14 ng/L
No Signiﬁcant Coronary Artery
Disease and hs-cTnT 14 ng/L Total
All physicians
Typical chest pain present 34 12 46
Typical chest pain absent 30 14 44
Total 64 26 90
Experienced physicians
Typical chest pain present 8 5 13
Typical chest pain absent 11 6 17
Total 19 11 30
Novice physicians
Typical chest pain present 26 7 33
Typical chest pain absent 19 8 27
Total 45 15 60
Signiﬁcant Coronary Artery
Disease and hs-cTnT <14 ng/L
No Signiﬁcant Coronary Artery
Disease and hs-cTnT <14 ng/L Total
All physicians
Typical chest pain present 11 19 30
Typical chest pain absent 17 20 37
Total 28 39 67
Experienced physicians
Typical chest pain present 2 3 5
Typical chest pain absent 8 6 14
Total 10 9 19
Novice physicians
Typical chest pain present 9 16 25
Typical chest pain absent 9 14 23
Total 18 30 48
Hs-cTnT ¼ high-sensitivity troponin-T elevation.
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